I(f) in non-pacemaker cells: role and pharmacological implications.
Pacemaker channels play a major role in the generation of sinoatrial rhythmic activity. However, their expression is not confined to specialized myocardial cells, such as primary and subsidiary pacemakers. Electrophysiological and molecular data collected over the last ten years have demonstrated that f-channels are also present in non-pacemaker cardiomyocytes, and become upregulated in cardiac hypertrophy and failure. Mislocalized expression and/or overexpression of f-channels are a consequence of electrophysiological remodeling and, from a clinical point of view, may represent an arrhythmogenic mechanism in heart failure, a condition associated with a high risk for sudden cardiac death. The potential arrhythmogenic role of I(f) and the availability of selective f-channel blockers cause I(f) to be a suitable therapeutic target in heart disease.
Cerbai
Elisabetta
E
Center of Molecular Medicine CIMMBA, Department of Preclinical and Clinical Pharmacology, Viale G. Pieraccini 6, 50139 Firenze, Italy. elisabetta.cerbai@unifi.it
Mugelli
Alessandro
A
D000818:Animals; D006325:Heart Atria / Q000166:cytology; D006331:Heart Diseases / Q000188:drug therapy* / Q000503:physiopathology; D006339:Heart Rate; D006352:Heart Ventricles / Q000166:cytology; D006801:Humans; D007473:Ion Channels / Q000037:antagonists & inhibitors / Q000502:physiology*; D032383:Myocytes, Cardiac / Q000502:physiology; D016276:Ventricular Function; D020257:Ventricular Remodeling
D007473:Ion Channels